Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers

URL

https://www.sciencedirect.com/science/article/pii/S1936878X21003569

Authors

George Joy, Jessica Artico, Hibba Kurdi, Andreas Seraphim, Clement Lau, George D. Thornton, Marta Fontes Oliveira, Robert Daniel Adam, Nikoo Aziminia, Katia Menacho, Liza Chacko, James T. Brown, Rishi K. Patel, Hunain Shiwani, Anish Bhuva, Joao B. Augusto, Mervyn Andiapen, Aine McKnight, Mahdad Noursadeghi, Iain Pierce, Timothée Evain, Gabriella Captur, Rhodri H. Davies, John P. Greenwood, Marianna Fontana, Peter Kellman, Erik B. Schelbert, Thomas A. Treibel, Charlotte Manisty, James C. Moon, on behalf of the COVIDsortium Investigator

Publication

JACC: Cardiovascular Imaging

Organization

University College London (UK)

Key Excerpts

“Objectives: The purpose of this study was to detect cardiovascular changes after mild severe acute respiratory syndrome-coronavirus-2 infection.

Background: Concern exists that mild coronavirus disease 2019 may cause myocardial and vascular disease…

Conclusions: Cardiovascular abnormalities are no more common in seropositive versus seronegative otherwise healthy, workforce representative individuals 6 months post–mild severe acute respiratory syndrome-coronavirus-2 infection.”

This is an Open Access article under the CC By-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Medium

document

Topics

adverse events,COVID-19,heart disorders,vaccines